SEC Filings - Supernus Pharmaceuticals

Filing date	Description	Form	Filing Group	View
November 10, 2016	Notification that form type 10-Q will be submitted late	NT 10-Q	Quarterly Filings	View HTML 0001104659-16-156274.pdf 0001104659-16-156274.xls
May 12, 2020	Notification that form type 10-Q will be submitted late	NT 10-Q	Quarterly Filings	View HTML 0001356576-20-000029.pdf 0001356576-20-000029.xls
August 11, 2020	Notification that form type 10-Q will be submitted late	NT 10-Q	Quarterly Filings	View HTML 0001356576-20-000048.pdf 0001356576-20-000048.xls
May 10, 2022	Notification that form type 10-Q will be submitted late	NT 10-Q	Quarterly Filings	View HTML 0001356576-22-000043.pdf 0001356576-22-000043.xls
March 26, 2014	A preliminary proxy statement providing notification matters to be brought to a vote	PRE 14A	Proxy Filings	View HTML 0001047469-14-003026.pdf 0001047469-14-003026.xls
March 6, 2006	REGDEX/A	REGDEX/A	Other	View HTML
November 14, 2012	Registration statement for face-amount certificate companies	S-1	Registration Statements	View HTML 0001047469-12-010489.pdf 0001047469-12-010489.xls
December 23, 2010	Registration statement for face-amount certificate companies	S-1	Registration Statements	View HTML 0001047469-10-010575.pdf 0001047469-10-010575.xls
November 26, 2012	Amended Registration statement for face-amount certificate companies	S-1/A	Registration Statements	View HTML 0001047469-12-010750.pdf 0001047469-12-010750.xls
November 28, 2012	Amended Registration statement for face-amount certificate companies	S-1/A	Registration Statements	View HTML 0001047469-12-010821.pdf 0001047469-12-010821.xls EX-101.INS - EX-101.INS

Data provided by Kaleidoscope.